Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001
European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8508-8513
DOI: 10.1007/s00259-026-08167-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 08.09.2026. Verfasst von Mark Lubberink und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Gallium Radioisotopes, Receptor, Platelet-Derived Growth Factor beta, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uppsala University.
Abstract (Originalsprache)
Purpose [ 68 Ga]Ga-ATH001 is an Affibody molecule targeting PDGFRβ in development as a Positron Emission Tomography (PET) tracer for non-invasive imaging of active fibrosis. Here we present first-in-human [ 68 Ga]Ga-ATH001 biodistribution and radiation dosimetry data.
Methods
Radiation dosimetry of [ 68 Ga]Ga-ATH001 was evaluated in healthy participants (n = 3) and participants with metabolic dysfunction-associated steatohepatitis (MASH) (n = 3). Each participant was intravenously administered ~ 2.5 MBq/kg [ 68 Ga]Ga-ATH001 and imaged by whole-body PET for up to 3 h post-injection. Absorbed dose coefficients and effective doses according to ICRP 103 were calculated using IDAC DOSE 2.1.
Results
The effective dose of [ 68 Ga]Ga-ATH001 was 0.028 ± 0.002 mSv/MBq with kidneys as the dose-limiting organ. Administration of a target dose of 2 MBq/kg would result in a sex-averaged effective dose of 4.1 mSv. Subjects tolerated the tracer administration well. Conclusion [ 68 Ga]Ga-ATH001 demonstrates a dosimetry and safety profile that supports further clinical development as a repeatable, non-invasive PET marker of active fibrosis in tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Takeda Development Center Americas, Inc, Cambridge, MA, USA.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Department of Nuclear Medicine and Medical Physics, Karolinska University Hospital, Stockholm, Sweden.
- Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
- Theranostics Trial Center, Karolinska Institutet, Stockholm, Sweden.
Förderung
- Uppsala University
Zitieren
APA
Lubberink, M., Lohith, T. G., Derdak, Z., Wilkens, P., Palmér, E., Ramolli, A., Ferrat, M., Tran, T. A., Mitran, B., Abouyzayed, A., Johansson, L., Wennbo, H., Rorsman, F., Vessby, J., & Eriksson, O. (2026). Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8508-8513. https://doi.org/10.1007/s00259-026-08167-9
Vancouver
Lubberink M, Lohith TG, Derdak Z, Wilkens P, Palmér E, Ramolli A, et al. Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8508-8513. doi:10.1007/s00259-026-08167-9
BibTeX
@article{Lubberink2026,
author = {Lubberink, Mark and Lohith, Talakad G and Derdak, Zoltan and Wilkens, Paul and Palmér, Emilia and Ramolli, Alexandra and Ferrat, Mélodie and Tran, Thuy A and Mitran, Bogdan and Abouyzayed, Ayman and Johansson, Lars and Wennbo, Haakan and Rorsman, Fredrik and Vessby, Johan and Eriksson, Olof},
title = {Biodistribution and radiation dosimetry of the PDGFRβ targeting PET tracer [68Ga]Ga-ATH001},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {13},
pages = {8508--8513},
doi = {10.1007/s00259-026-08167-9}
}
EUVIMED